Home » Thought Leadership

Thought Leadership

Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 5 of 8 posts
October 29, 2020 | Blog

2020 USA Election & Drug Pricing Outlook

An analysis of the key drug pricing proposals in the 2020 USA Election in terms of political focus, party priorities, implementation feasibility, and potential risk to biopharma.

August 5, 2020 | Blog

Misconceptions of the 340B Drug Discount Program

Since its inception over 30 years ago, the 340B drug pricing program policy has evolved allowing for unprecedented expansion and influence. With this it has also become highly contested, especially in recent years as more legislation has been put forward to close 340B loopholes.

Speaking of Access: The Management of Tumor-Agnostic Therapies from CBPartners
June 5, 2019 | Videos

What is the likelihood of increased site-of-care restrictions among US payers?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers what is the likelihood of increased site-of-care-restrictions is among them.

Speaking of Access: The Management of Tumor-Agnostic Therapies from CBPartners
May 28, 2019 | Videos

Which disease states are on US payers’ radar?

US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers which disease states are currently on their radar.